Tag pharmaceuticals [44 articles] Export

Recent papers classified by the tag pharmaceuticals.

	The Organometallic Fluorine Chemistry of Palladium and Rhodium: Studies toward Aromatic Fluorination [My Copy] Accounts of Chemical Research, Vol. 0, No. 0. (0000) by Vladimir V. Grushin posted to rhodium pharmaceuticals palladium fluorine fluorination aromatic by wozzza to the group Cross Research Group on 2009-09-30 11:33:21 as
	Supranational regulatory agencies between independence and control: the EMEA and the authorization of pharmaceuticals in the European Single Market [My Copy] Journal of European Public Policy (March 2007), pp. 208-226. by Thomas Gehring, Sebastian Krapohl posted to regulation pharmaceuticals eu emea by henningninneh on 2009-09-23 08:31:08 as
	Economics of biological therapies [My Copy] BMJ, Vol. 339, No. aug21_1. (21 August 2009), b3276. by Christopher J. Kelly, Fraz A. Mir posted to resource_allocation pharmaceuticals ethics biotherapeutics by chriswillmott on 2009-09-20 09:57:15 as
	Impact of Nanotechnology on Drug Delivery [My Copy] ACS Nano, Vol. 3, No. 1. (27 January 2009), pp. 16-20. by Omid C. Farokhzad, Robert Langer posted to pharmaceuticals nanotechnology drug_delivery by chriswillmott on 2009-09-02 13:24:20 as along with 2 people and 1 group flbarroso sobolevnrm baker-group
	Product Cycles, Innovation, and Exports: A Study of Indian Pharmaceuticals [My Copy] World Development, Vol. 37, No. 9. (17 September 2009), pp. 1478-1483. by Alka Chadha posted to cycles exports indian innovation pharmaceuticals product study by derchao on 2009-08-07 17:05:10 as
	Improving Health R&D Financing For Developing Countries: A Menu Of Innovative Policy Options [My Copy] Health Aff, Vol. 28, No. 4. (1 July 2009), pp. 974-985. by Robert Hecht, Paul Wilson, Amrita Palriwala posted to development financing health pharmaceuticals by lorainehawkins on 2009-07-30 11:23:47 as
	Human pharmaceuticals in US surface waters: A human health risk assessment [My Copy] Regulatory Toxicology and Pharmacology, Vol. 42, No. 3. (August 2005), pp. 296-312. by B. Schwab, E. Hayes, J. Fiori, et al.F. Mastrocco, N. Roden, D. Cragin, R. Meyerhoff, V. Daco, P. Anderson posted to pharmaceuticals risk by Polyquats on 2009-07-09 04:39:15 as
	Types and quantities of leftover drugs entering the environment via disposal to sewage — Revealed by coroner records☆ [My Copy] Science of The Total Environment, Vol. 388, No. 1-3. (15 December 2007), pp. 137-148. by I. Ruhoy, C. Daughton posted to pharmaceuticals risk by Polyquats on 2009-07-09 03:05:48 as along with 1 person charlesmoore
	In vitro analysis of inflammatory responses following environmental exposure to pharmaceuticals and inland waters [My Copy] Science of The Total Environment, Vol. 407, No. 4. (01 February 2009), pp. 1452-1460. by H. Khalaf, L. Salste, P. Karlsson, P. Ivarsson, J. Jass, P. Olsson posted to biomonitoring in_vitro pharmaceuticals risk by Polyquats on 2009-07-09 02:59:21 as
	Selecting Scenarios to Assess Exposure of Surface Waters to Veterinary Medicines in Europe [My Copy] Environmental Science & Technology, Vol. 41, No. 13. (1 July 2007), pp. 4669-4676. by Manuel K. Schneider, Christian Stamm, Kathrin Fenner posted to pharmaceuticals risk by Polyquats on 2009-07-09 02:53:52 as
	Human Pharmaceuticals in the Aquatic Environment: A Challenge to Green Chemistry [My Copy] Chemical Reviews, Vol. 107, No. 6. (1 June 2007), pp. 2319-2364. by Sushil K. Khetan, Terrence J. Collins posted to pharmaceuticals risk by Polyquats on 2009-07-09 02:49:36 as
	Trends in the detection of pharmaceutical products, and their impact and mitigation in water and wastewater in North America [My Copy] Analytical and Bioanalytical Chemistry, Vol. 387, No. 4. (1 February 2007), pp. 1143-1151. by Isabelle Robinson, Guillaume Junqua, Raymond Van Coillie, Olivier Thomas posted to pharmaceuticals risk by Polyquats on 2009-07-09 02:44:38 as
	Trends in human risk assessment of pharmaceuticals [My Copy] Analytical and Bioanalytical Chemistry, Vol. 387, No. 4. (1 February 2007), pp. 1167-1172. by J. Dorne, A. M. J. Ragas, G. K. Frampton, D. S. Spurgeon, D. F. Lewis posted to pharmaceuticals risk by Polyquats on 2009-07-09 02:37:41 as
	Occurrence patterns of pharmaceuticals in water and wastewater environments [My Copy] Analytical and Bioanalytical Chemistry, Vol. 387, No. 4. (1 February 2007), pp. 1225-1234. by Anastasia Nikolaou, Sureyya Meric, Despo Fatta posted to pharmaceuticals risk by Polyquats on 2009-07-09 02:31:55 as
	Human and environmental risk assessment of pharmaceuticals: differences, similarities, lessons from toxicology [My Copy] Analytical and Bioanalytical Chemistry, Vol. 387, No. 4. (1 February 2007), pp. 1259-1268. by J. Dorne, L. Skinner, G. Frampton, D. Spurgeon, A. Ragas posted to pharmaceuticals risk by Polyquats on 2009-07-09 02:27:07 as
	Pharmaceuticals and personal care products in biosolids/sewage sludge: the interface between analytical chemistry and regulation [My Copy] Analytical and Bioanalytical Chemistry, Vol. 387, No. 4. (1 February 2007), pp. 1173-1183. by T. Jones-Lepp, Rick Stevens posted to pharmaceuticals risk by Polyquats on 2009-07-09 02:25:54 as
	Pharmaceuticals and personal care products (PPCPs) in the environment [My Copy] Analytical and Bioanalytical Chemistry, Vol. 387, No. 4. (1 February 2007), pp. 1141-1142. by Damià Barceló, Mira Petrovic posted to pharmaceuticals risk by Polyquats on 2009-07-09 02:21:04 as
	Integrated approach to the problem of pharmaceutical products in the environment: an overview [My Copy] Analytical and Bioanalytical Chemistry, Vol. 387, No. 4. (1 February 2007), pp. 1163-1166. by Clemence Coetsier, Liming Lin, Benoit Roig, Evelyne Touraud posted to pharmaceuticals risk by Polyquats on 2009-07-09 02:16:54 as
	Occurrence and analysis of pharmaceuticals and their transformation products in drinking water treatment [My Copy] Analytical and Bioanalytical Chemistry, Vol. 387, No. 4. (1 February 2007), pp. 1159-1162. by C. Zwiener posted to pharmaceuticals risk by Polyquats on 2009-07-09 02:10:32 as
	Peer Reviewed: Scrutinizing Pharmaceuticals and Personal Care Products in Wastewater Treatment [My Copy] Environmental Science & Technology, Vol. 38, No. 20. (1 October 2004), pp. 392A-399A. by Thomas A. Ternes, Adriano Joss, Hansruedi Siegrist posted to care personal pharmaceuticals products by ahaa572 on 2009-04-08 07:41:09 as
	Endocrine Disrupting Chemicals: Human Exposure and Health Risks [My Copy] Journal of Environmental Science and Health, Part C, Vol. 24, No. 2. (2006), pp. 183-224. by Mihi Yang, Mi S. Park, Ho S. Lee posted to edcs pharmaceuticals by JLampard on 2008-12-08 05:43:40 as along with 1 person calvin
	Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources – a review [My Copy] Chemosphere, Vol. 45, No. 6-7. (November 2001), pp. 957-969. by K. Kümmerer posted to hospitals pharmaceuticals by hrc on 2008-11-23 22:30:07 as along with 1 person charlesmoore
	Pharmaceuticals: a threat to drinking water? [My Copy] Trends in Biotechnology, Vol. 23, No. 4. (April 2005), pp. 163-167. by O. Jones, J. Lester, N. Voulvoulis posted to drinking pharmaceuticals water by hrc on 2008-11-13 03:29:51 as
	Off-Label Promotion, On-Target Sales [My Copy] PLoS Medicine, Vol. 5, No. 10. (1 October 2008), e210. by Adriane Fugh-Berman, Douglas Melnick posted to drugs off-label_prescribing pharmaceuticals presciption_medications by HEIRS to the group HEIRS Telemedicine & Access of Care on 2008-10-28 12:44:49 as along with 4 groups HEIRS Pharmacy and Drug Research HEIRS Health HEIRS - Environmental Illness Research HEIRS Disabilities, Benefits and the Law
	The Anxieties of Globalization: Antidepressant Sales and Economic Crisis in Argentina [My Copy] Social Studies of Science, Vol. 34, No. 2. (1 April 2004), pp. 247-269. by Andrew Lakoff posted to antidepressantmarketing antidepressants argentina audit gifteconomy marketing neoliberalism pharmaceuticals psychiatry by erinem on 2008-09-28 05:52:30 as along with 1 person amaria
	Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 50. (13 December 2005), pp. 18195-18200. by G. D. Iannetti, L. Zambreanu, R. G. Wise, et al.T. J. Buchanan, J. P. Huggins, T. S. Smart, W. Vennart, I. Tracey posted to fmri pain pharmaceuticals by eugeneduff on 2008-08-21 09:22:11 as
	Pains, gains, and midbrains. [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 50. (13 December 2005), pp. 17885-17886. by A. H. Dickenson, L. A. Bee, R. Suzuki posted to commentry fmri pain pharmaceuticals by eugeneduff on 2008-08-21 09:20:58 as
	Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs [My Copy] (18 March 2008) by Melody Petersen posted to books health-care pharmaceuticals teaching-statistics by jklugman on 2008-06-16 12:53:20 as
	FDA Drops Helsinki Rules [My Copy] Science, Vol. 320, No. 5877. (9 May 2008), 731b. by Jennifer Couzin posted to ethics fda pharmaceuticals by kkaplon11 on 2008-05-09 14:49:46 as
	`I'd rather not take Prozac': stigma and commodification in antidepressant consumer narratives [My Copy] Health (London), Vol. 12, No. 1. (1 January 2008), pp. 67-86. by Regina Smardon posted to antidepressantbranding antidepressants commodification consumerculture consumption culture depression identity mentalillness narrative pharmaceuticals prozac psychotropicmedications stigma by erinem on 2008-04-20 05:14:43 as
	Access to vaccine technologies in developing countries: Brazil and India [My Copy] Vaccine, Vol. 25, No. 44. (1 November 2007), pp. 7610-7619. by Julie B. Milstien, Patrick Gaule, Miloud Kaddar posted to brazil development india patents pharmaceuticals reform trips vaccines by BigRedBall on 2008-02-06 20:34:01 as along with 1 person PCHACON
	Expanding drug access in Brazil: lessons for Latin America and Canada. [My Copy] Can J Public Health, Vol. 97, No. 6. (c 2006), pp. I-15-I-18. by J. C. Cohen posted to brazil canada pharmaceuticals strategies by BigRedBall on 2008-01-29 13:13:06 as along with 1 person cmmorel
	Four Lessons for Developing Countries from the Trade Negotiations Over Access to Medicines [My Copy] Liverpool Law Review, Vol. 28, No. 1. (April 2007), pp. 11-39. by Drahos, Peter posted to development negotiations pharmaceuticals toget trips wto by BigRedBall on 2008-01-10 00:13:49 as along with 1 person and 3 groups jago Integrative Expertise for Global Health Patent_Reform Convention on Knowledge Commons
	Evolution of Antiretroviral Drug Costs in Brazil in the Context of Free and Universal Access to AIDS Treatment [My Copy] PLoS Medicine, Vol. 4, No. 11. (1 November 2007), e305. by Amy S. Nunn, Elize M. Fonseca, Francisco I. Bastos, Sofia Gruskin, Joshua A. Salomon posted to aids brazil compulsory-license drugs economics hiv patents pharmaceuticals by BigRedBall on 2007-11-24 22:05:01 as along with 1 person cmmorel
	Pills, Power, People: Sociological Understandings of the Pharmaceutical Industry [My Copy] Sociology, Vol. 40, No. 2. (1 April 2006), pp. 297-314. by Joan Busfield posted to actor-networks pharmaceuticals sts by ricmilne on 2007-11-02 09:33:02 as along with 1 person ultrascichick
	Management of Diabetic Peripheral Neuropathy [My Copy] Clin Diabetes, Vol. 23, No. 1. (1 January 2005), pp. 9-15. by Andrew J. Boulton posted to adjuvant diabetes endocrinology idiopathic medications medicine medicines neurology neuropathies neuropathy non-diabetic non-opioids opioids pain peripheral pharmaceuticals pharmacology pharmacotherapy rx by avivagabriel on 2007-10-08 21:10:53 as
	Pharmaceutical Patents, Prices and Welfare Losses: Policy Options for India Under the WTO TRIPS Agreement [My Copy] The World Economy, Vol. 23, No. 5. (2000), pp. 733-752. by Jayashree Watal posted to india intellectual-property patents pharmaceuticals treaty trips welfare wto by BigRedBall on 2007-09-05 00:28:35 as
	Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines [My Copy] Cad Saude Publica, Vol. 23, No. 2. (February 2007), pp. 257-267. by G. C. Chaves, M. A. Oliveira, L. Hasenclever, L. M. de Melo posted to access ipr patents pharmaceuticals by cmmorel on 2007-02-12 15:45:01 as
	Public production of medicines in Brazil: an overview [My Copy] Cad Saude Publica, Vol. 22, No. 11. (November 2006), pp. 2379-2389. by E. A. de Oliveira, M. E. Labra, J. Bermudez posted to brasil brazil drug_development medicines pharmaceuticals production by cmmorel on 2006-11-13 09:25:24 as
	Inverse drug screens: a rapid and inexpensive method for implicating molecular targets. [My Copy] Genesis, Vol. 44, No. 11. (November 2006), pp. 530-540. by D. S. Adams, M. Levin posted to drug drug_discovery drug_targets molecular_targets pharmaceuticals by cmmorel on 2006-11-10 14:49:29 as
	Price competition in the chinese pharmaceutical market [My Copy] International Journal of Health Care Finance and Economics, Vol. 6, No. 2. (June 2006), pp. 119-129. by Wang, Y. posted to astrazeneca china competition pharmaceuticals price by gsk3 on 2006-10-26 15:30:59 as
	'Smart drugs': do they work? Are they ethical? Will they be legal? [My Copy] Nature Reviews. Neuroscience, Vol. 3, No. 12. (December 2002), pp. 975-979. by Steven P. Rose posted to ethics neuroethics neuroscience pharmaceuticals by sxtae on 2006-05-15 17:48:11 as along with 1 person Scis0000002
	The druggable genome: an update. [My Copy] Drug Discov Today, Vol. 10, No. 23-24. (December 2005), pp. 1607-1610. by A. P. Russ, S. Lampel posted to pharmaceuticals by eweaver on 2006-02-22 04:17:10 as along with 5 people and 3 groups ucbcjbm Yanno kuhn marcius caporaso biomedical-nlp BioinfoCIPF SGU-CIPF
	Foreign free riders and the high price of US medicines [My Copy] BMJ, Vol. 331, No. 7522. (22 October 2005), pp. 958-960. by Donald W. Light, Joel Lexchin posted to incentives pharmaceuticals pricing production profits by gsk3 on 2005-11-29 21:41:38 as along with 1 person INFA

Note: You may cite this page as: http://www.citeulike.org/tag/pharmaceuticals

risk	13
drugs	7
off-label_prescribing	6
presciption_medications	6
brazil	4
patents	4
aromatic	3
development	3
ethics	3
fluorination	3
fluorine	3
pain	3
palladium	3
rhodium	3
trips	3
antidepressants	2
fmri	2
india	2
medicines	2
production	2
wto	2
access	1
aids	1
antidepressantbranding	1
antidepressantmarketing	1
argentina	1
audit	1
biomonitoring	1
biotherapeutics	1
brasil	1
canada	1
china	1
commentry	1
commodification	1
competition	1
consumerculture	1
consumption	1
culture	1
cycles	1
depression	1
drinking	1
drug	1
drug_delivery	1
drug_development	1
drug_discovery	1
drug_targets	1
economics	1
edcs	1
emea	1
endocrinology	1
eu	1
exports	1
fda	1
financing	1
gifteconomy	1
health	1
health-care	1
hiv	1
identity	1
idiopathic	1
in_vitro	1
incentives	1
indian	1
innovation	1
ipr	1
medications	1
medicine	1
molecular_targets	1
nanotechnology	1
negotiations	1
neoliberalism	1
neuroethics	1
neurology	1
neuropathy	1
neuroscience	1
non-diabetic	1
non-opioids	1
opioids	1
personal	1
pharmacology	1
pharmacotherapy	1
price	1
pricing	1
profits	1
prozac	1
psychiatry	1
psychotropicmedications	1
regulation	1
resource_allocation	1
rx	1
stigma	1
strategies	1
sts	1
study	1
teaching-statistics	1
toget	1
treaty	1
vaccines	1
water	1
welfare	1

Tag pharmaceuticals [44 articles] Export

Related Tags